David H Van Thiel

Author PubWeight™ 38.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003 2.18
2 Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002 1.49
3 Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl 2003 1.19
4 Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology 2004 1.10
5 Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 2004 1.05
6 Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients. Sex Transm Dis 2007 1.04
7 The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol 2002 0.96
8 Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol 2013 0.91
9 Current concepts and management approaches in nonalcoholic fatty liver disease. ScientificWorldJournal 2013 0.91
10 Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C. J Med Virol 2002 0.91
11 Reactivation of sarcoidosis during interferon therapy. J Gastroenterol 2002 0.90
12 Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation. Clin Transplant 2003 0.88
13 Liver transplantation for alcoholic liver disease. Alcohol Res Health 2003 0.87
14 Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines. Alcohol Clin Exp Res 2003 0.87
15 Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis. Eur J Gastroenterol Hepatol 2008 0.87
16 Hepatic estrogen receptors and alcohol intake. Mol Cell Endocrinol 2002 0.85
17 Impaired response to high-dose interferon treatment in African-Americans with chronic hepatitis C. Hepatogastroenterology 2002 0.85
18 Biomarkers of Oxidative Stress Study IV: ozone exposure of rats and its effect on antioxidants in plasma and bronchoalveolar lavage fluid. Free Radic Biol Med 2011 0.84
19 Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayub Med Coll Abbottabad 2011 0.81
20 Post-transplant IVC occlusion and thrombosis treated with tPA, heparin, and sharp recanalization. J Gastroenterol 2005 0.81
21 Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin. Dig Dis Sci 2011 0.80
22 A comparison of risk factors for HCV-mono-infection, HIV-mono-infection, and HCV/HIV-co-infection in a community setting. Dig Dis Sci 2007 0.80
23 Cardiovascular problems in cirrhotic patients. Turk J Gastroenterol 2004 0.79
24 Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci 2003 0.79
25 Hepatitis C virus-associated pericardial effusion and tamponade in a liver transplant recipient. Can J Cardiol 2004 0.79
26 Effects of soybean extract on morphology and survival of Caco-2, SW620, and HT-29 cells. Nutr Cancer 2002 0.79
27 Luminescence experiments involved in the mechanism of streptozotocin diabetes and cataract formation. Luminescence 2008 0.79
28 Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency. Hepatogastroenterology 2003 0.78
29 Ultrasensitive peroxynitrite-based luminescence with L-012 as a screening system for antioxidative/antinitrating substances, e.g. Tylenol (acetaminophen), 4-OH tempol, quercetin and carboxy-PTIO. Luminescence 2007 0.78
30 Daily interferon therapy for chronic hepatitis C: a report of a community practice experience. Hepatogastroenterology 2002 0.78
31 Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma. Hepatogastroenterology 2004 0.78
32 Use of recombinant factor VIIa to correct the coagulation status of individuals with advanced liver disease prior to a percutaneous liver biopsy. Dig Dis Sci 2009 0.78
33 Hemostatic modulation with the liver dialysis device in humans with advanced liver disease. Hepatogastroenterology 2002 0.77
34 Celiac disease in patients with HCV genotype 1A. Am J Gastroenterol 2003 0.77
35 Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. Cytokine 2004 0.77
36 Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation. Liver Transpl 2005 0.77
37 Transjugular liver biopsy: comparison of sample adequacy with the use of two automated needle systems. J Vasc Interv Radiol 2010 0.77
38 Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals. Hepatogastroenterology 2003 0.76
39 Calponin is expressed by Sertoli cells within rat testes and is associated with actin-enriched cytoskeleton. Cell Tissue Res 2004 0.76
40 HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy. Dig Dis Sci 2006 0.76
41 Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig Dis Sci 2003 0.75
42 Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant 1993 0.75
43 Colonic diffuse large B-cell lymphoma in a liver transplant patient with historically very low tacrolimus levels. Case Rep Transplant 2012 0.75
44 Nonocclusive mesenteric ischemia: reality. J Gastroenterol 2002 0.75
45 Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient. Chest 2003 0.75
46 Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols. South Med J 2005 0.75
47 Complete esophagogastric anastomotic disruption. Gastrointest Endosc 2003 0.75
48 Hepatic iron quantitation and its relationship with disease measures and histologically assessed iron content. Dig Dis Sci 2007 0.75
49 Ascites and kidney transplantation: case report and critical appraisal of the literature. Dig Dis Sci 2007 0.75
50 Postoperative infections in cirrhotic patients. Hepatogastroenterology 2005 0.75
51 Adenocarcinoma of the ileocecal valve occurring 35 years after jejunoileal bypass. South Med J 2008 0.75
52 An assessment of the accuracy of hepatic and splenic size based upon a clinician's physical examination, a radiologist's impression and the actual liver and spleen volumes calculated by CT scanning. Dig Dis Sci 2008 0.75
53 First report of telaprevir-induced pancreatitis. Dig Dis Sci 2013 0.75
54 Retroperitoneal varices presenting as an adrenal pseudotumor in a cirrhotic patient. WMJ 2006 0.75
55 Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa. Hepatogastroenterology 2003 0.75